Kestra Medical Technologies Q4 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 14, 2026.
Q4 2026
EPS
$-0.67
est $-0.58
-15.5%
Revenue
$29M
est $26M
+8.2%
Kestra crushed revenue expectations with a 66% year-over-year surge in wearable defibrillator demand, but losses deepened as the company aggressively scaled its commercial team. The miss on earnings per share signals the bet is all in on FY27 guidance of 44% revenue growth.
Mentioned: KMTS